These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 14628097)
1. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097 [TBL] [Abstract][Full Text] [Related]
2. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686 [TBL] [Abstract][Full Text] [Related]
3. [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Giovacchini G; Picchio M; Coradeschi E; Scattoni V; Bettinardi V; Cozzarini C; Freschi M; Fazio F; Messa C Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1065-73. PubMed ID: 18200444 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Kato T; Tsukamoto E; Kuge Y; Takei T; Shiga T; Shinohara N; Katoh C; Nakada K; Tamaki N Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1492-5. PubMed ID: 12397469 [TBL] [Abstract][Full Text] [Related]
5. Imaging prostate cancer with 11C-choline PET/CT. Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001 [TBL] [Abstract][Full Text] [Related]
6. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Breeuwsma AJ; Pruim J; Jongen MM; Suurmeijer AJ; Vaalburg W; Nijman RJ; de Jong IJ Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):668-73. PubMed ID: 15765234 [TBL] [Abstract][Full Text] [Related]
8. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. Castellucci P; Fuccio C; Nanni C; Santi I; Rizzello A; Lodi F; Franceschelli A; Martorana G; Manferrari F; Fanti S J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023 [TBL] [Abstract][Full Text] [Related]
9. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Scher B; Seitz M; Albinger W; Tiling R; Scherr M; Becker HC; Souvatzogluou M; Gildehaus FJ; Wester HJ; Dresel S Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):45-53. PubMed ID: 16932935 [TBL] [Abstract][Full Text] [Related]
10. Deep learning-based quantification of PET/CT prostate gland uptake: association with overall survival. Polymeri E; Sadik M; Kaboteh R; Borrelli P; Enqvist O; Ulén J; Ohlsson M; Trägårdh E; Poulsen MH; Simonsen JA; Hoilund-Carlsen PF; Johnsson ÅA; Edenbrandt L Clin Physiol Funct Imaging; 2020 Mar; 40(2):106-113. PubMed ID: 31794112 [TBL] [Abstract][Full Text] [Related]
12. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Sutinen E; Jyrkkiö S; Alanen K; Någren K; Minn H Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):72-7. PubMed ID: 12483412 [TBL] [Abstract][Full Text] [Related]
13. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Beer AJ; Eiber M; Souvatzoglou M; Holzapfel K; Ganter C; Weirich G; Maurer T; Kübler H; Wester HJ; Gaa J; Krause BJ Mol Imaging Biol; 2011 Apr; 13(2):352-61. PubMed ID: 20490932 [TBL] [Abstract][Full Text] [Related]
14. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer]. García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948 [TBL] [Abstract][Full Text] [Related]
15. [[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model]. Schwarzenböck S; Sachs D; Souvatzoglou M; Schuster T; Nawroth R; Weirich G; Treiber U; Wester HJ; Ziegler S; Schwaiger M; Senekowitsch-Schmidtke R; Krause BJ Nuklearmedizin; 2013; 52(4):141-7. PubMed ID: 23396481 [TBL] [Abstract][Full Text] [Related]
16. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491 [TBL] [Abstract][Full Text] [Related]
17. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning. Garcia JR; Jorcano S; Soler M; Linero D; Moragas M; Riera E; Miralbell R; Lomeña F Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):342-50. PubMed ID: 24844254 [TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans. Chang JH; Lim Joon D; Lee ST; Gong SJ; Anderson NJ; Scott AM; Davis ID; Clouston D; Bolton D; Hamilton CS; Khoo V Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e691-6. PubMed ID: 22658218 [TBL] [Abstract][Full Text] [Related]
19. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model. Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088 [TBL] [Abstract][Full Text] [Related]
20. Visualization of prostate cancer with 11C-choline positron emission tomography. de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ Eur Urol; 2002 Jul; 42(1):18-23. PubMed ID: 12121724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]